| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.007 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.17 | 0.008 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |